Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved trial
Diabetes Care 2017;40:14691478 [DOI] [PubMed] [Google Scholar] 49.Hauber AB, Nguyen H, Posner J, Kalsekar I, Ruggles J
The most frequently reported side effects of Wegovy are gastrointestinal in nature, including nausea (very common, 1/10), vomiting, diarrhoea, constipation, and abdominal pain
Something went wrong Please contact your administrator
Obes Metab 18:508518 Ghanem SS, Heinrich G, Lester SG et al (2016) Increased glucose-induced secretion of glucagon-like peptide-1 in mice lacking the carcinoembryonic antigen-related cell adhesion molecule 2 (CEACAM2)